BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7970505)

  • 1. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Bernath AM; Schaid DJ; Malliard JA; Athmann LM; Michalak JC; Tschetter LK; Hatfield AK; Morton RF
    Oncology; 1994 Oct; 51 Suppl 1():2-7. PubMed ID: 7970505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
    J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia.
    Von Roenn JH
    Oncology; 1994 Oct; 51 Suppl 1():19-24. PubMed ID: 7970504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ
    J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
    Loprinzi CL; Ellison NM; Schaid DJ; Krook JE; Athmann LM; Dose AM; Mailliard JA; Johnson PS; Ebbert LP; Geeraerts LH
    J Natl Cancer Inst; 1990 Jul; 82(13):1127-32. PubMed ID: 2193166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.
    Von Roenn JH; Murphy RL; Wegener N
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol acetate for anorexia and cachexia.
    Loprinzi CL; Johnson PA; Jensen M
    Oncology; 1992; 49 Suppl 2():46-9. PubMed ID: 1461628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
    Gebbia V; Testa A; Gebbia N
    Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and benefits of various therapies for cancer anorexia.
    Schmoll E
    Oncology; 1992; 49 Suppl 2():43-5. PubMed ID: 1461627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite stimulation and weight gain with megestrol acetate.
    Aisner J; Parnes H; Tait N; Hickman M; Forrest A; Greco FA; Tchekmedyian NS
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):2-7. PubMed ID: 2259925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bristol-Myers Anorexia/Cachexia Recovery Instrument (BACRI): a brief assessment of patients' subjective response to treatment for anorexia/cachexia.
    Cella DF; VonRoenn J; Lloyd S; Browder HP
    Qual Life Res; 1995 Jun; 4(3):221-31. PubMed ID: 7613532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
    Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B
    J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of anorexia with megestrol acetate.
    Tchekmedyian NS
    Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
    Berenstein EG; Ortiz Z
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate in patients with AIDS-related cachexia.
    Von Roenn JH; Armstrong D; Kotler DP; Cohn DL; Klimas NG; Tchekmedyian NS; Cone L; Brennan PJ; Weitzman SA
    Ann Intern Med; 1994 Sep; 121(6):393-9. PubMed ID: 7794302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose megestrol acetate for appetite stimulation in advanced cancer.
    Donnelly S; Walsh TD
    J Pain Symptom Manage; 1995 Apr; 10(3):182-3. PubMed ID: 7629410
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.
    Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I
    Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appetite stimulation with megestrol acetate in cachectic cancer patients.
    Tchekmedyian NS; Tait N; Moody M; Greco FA; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):37-43. PubMed ID: 3798127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind clinical trial of combined treatment with megestrol acetate plus celecoxib versus megestrol acetate alone in cachexia-anorexia syndrome induced by GI cancers.
    Kouchaki B; Janbabai G; Alipour A; Ala S; Borhani S; Salehifar E
    Support Care Cancer; 2018 Jul; 26(7):2479-2489. PubMed ID: 29442239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate: clinical experience.
    Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L
    Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.